Comprehensive Analysis Based on the Cancer Immunotherapy and Immune Activation of Gastric Cancer Patients

Figure 9

(a) The GSEA analysis based on E2F2; (b) the GSEA analysis based on THSD7A; (c) the GSVA analysis based on the risk score and key genes involved in GC cohort.

(a)

(b)

(c)